EUSA Pharma welcomes applications from healthcare professionals (HCPs) wishing to apply for grants to conduct research as part of an investigator initiated research (IIR) programme.
EUSA Pharma has a strict policy for assessing all applications for IIR grants. No application will be judged on the basis of past, present or future intention or willingness to prescribe, use or recommend EUSA Pharma products, and all applications will be assessed according to the merits of the study in terms of the quality of the proposed clinical research.
No research grant funding will be provided without ethics committee or similar approval of the research proposal. All studies will be expected to be original research that will not replicate previous or on-going studies, and to have a documented statistical plan that demonstrates that the proposed research has adequate power to assess the defined primary objective.